Hyperion DeFi (HYPD)
NASDAQ:HYPD
Want to see HYPD full AI Analyst Report?
Top Page
Hyperion DeFi
(NASDAQ:HYPD)
Select Model
Select Model
Rating:47Neutral
Price Target:
$3.00
▼(-22.08% Downside)
Action:Reiterated
Date:06/26/26
The overall score is held down primarily by very weak underlying financial performance (outsized losses and significant cash burn) and a weak technical setup (trading below major moving averages with negative MACD). The earnings call provides the main offset via raised guidance, improved reported profitability metrics, and a stated path to cash-flow breakeven, but valuation support is limited given the negative P/E and lack of dividend yield data.
Positive Factors
Partnerships & Product Traction
Sustained product traction and strategic partnerships (HIP3 market share and a high‑impact HIP4 launch) signal durable network effects and product-market fit. This supports recurring fee and monetization opportunities, making growth less reliant on short-term token moves and more on platform adoption.
Negative Factors
Severe Cash Burn
Large and persistent negative operating and free cash flow create ongoing financing needs and dilution risk. Even with recent raises, continued cash burn forces reliance on external capital or asset sales, constraining strategic optionality and increasing execution pressure to reach breakeven within the stated timeframe.
Read all positive and negative factors
Positive Factors
Negative Factors
Partnerships & Product Traction
Sustained product traction and strategic partnerships (HIP3 market share and a high‑impact HIP4 launch) signal durable network effects and product-market fit. This supports recurring fee and monetization opportunities, making growth less reliant on short-term token moves and more on platform adoption.
Read all positive factors
Hyperion DeFi (HYPD) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$46.38M
Dividend YieldN/A
Average Volume (3M)1.09M
Price to Earnings (P/E)―
Beta (1Y)3.26
Revenue Growth1455.26%
EPS Growth85.26%
CountryUS
Employees13
SectorHealthcare
Sector Strength45
IndustryMedical - Devices
Share Statistics
EPS (TTM)-14.46
Shares Outstanding15,157,747
10 Day Avg. Volume701,310
30 Day Avg. Volume1,085,571
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.43
Price to Sales (P/S)21.88
P/FCF Ratio-1.21
Enterprise Value/Market Cap0.42
Enterprise Value/Revenue18.51
Enterprise Value/Gross Profit29.07
Enterprise Value/Ebitda-0.61
Forecast
1Y Price Target
$7.30Price Target Upside89.61% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.83
Revenue Forecast (FY)$8.77M
Hyperion DeFi Business Overview & Revenue Model
Company Description
Operating from the United States, Hyperion DeFi, Inc. is a company undergoing a significant shift from its foundational work in ophthalmic drug-delivery, known as Optejet. Its current trajectory involves establishing itself as the inaugural U.S. f...
How the Company Makes Money
null...
Hyperion DeFi Earnings Call Summary
Earnings Call Date:May 14, 2026
(Q1-2026)
| % Change Since: |
Next Earnings Date:Aug 12, 2026
Earnings Call Sentiment Positive
The call signals strong operational and financial momentum: raised guidance (+20%), material quarter-over-quarter growth in adjusted gross profit (+17 vs prior quarter; +119 vs Q3), significant segment-level acceleration (DeFi monetization +140%, yield enhancement +165%), record Q1 GAAP net income ($8.8M) and improved balance sheet/treasury values (over 2M HYPE, NAV growth, treasury gains). Strategic partnerships (Silhouette, HyperLend, Kinetiq, Rysk) and core product traction (HIP3 ~50% of trading activity; HIP4 launch success) provide clear growth avenues. Offsetting risks include continuing operating cash burn (~$4.2M used in Q1), volatile ecosystem awards and HYPE price swings, GAAP presentation complexities around validator income and reliance on non-GAAP metrics, and regulatory uncertainty for outcome/prediction markets. On balance, positives materially outweigh the negatives given the jump to profitability, strengthened treasury and expanded guidance, though execution and regulatory risks remain.Positive Updates
Raised 2026 Adjusted Gross Profit Guidance
Increased full-year 2026 adjusted gross profit guidance from $4M–$6M to $5M–$7M (approximately +20% or +$1M), driven by momentum in DeFi businesses and a $10M public offering.
Negative Updates
Volatility and Decline in Ecosystem Awards
Ecosystem awards fell to $150k in Q1 from $285k in Q4; management notes ecosystem rewards are variable and timing of airdrops/token events is unpredictable, creating quarter-to-quarter volatility in this revenue component.
Read all updates
Q1-2026 Updates
Positive
Negative
Raised 2026 Adjusted Gross Profit Guidance
Increased full-year 2026 adjusted gross profit guidance from $4M–$6M to $5M–$7M (approximately +20% or +$1M), driven by momentum in DeFi businesses and a $10M public offering.
Read all positive updates
Company Guidance
Hyperion raised full‑year 2026 adjusted gross profit guidance by ~20% (up $1.0M) to $5.0–$7.0M and reiterated a target of cash‑flow breakeven by year‑end 2026 after closing a $10M public equity raise (≈$9M net) and ATM proceeds. In Q1 the company delivered $960k of adjusted gross profit (up 119% vs Q3 and +17% sequentially), with staking earning ~10,100 HYPE (~$313k AGP), validator commissions ~1,300 HYPE (~$40k), yield enhancement $211k (+165% QoQ), DeFi monetization $245k (+140% QoQ) and ecosystem awards $150k (including 10M HPL = 1% supply); treasury HYPE moved 1.88M → 1.94M → >2M (Q4→Q1→May 11), average HYPE price fell 45.8 → 35.1 → 30.8 (Q3→Q4→Q1) while end‑period price rose 25.4 → 36.6 → 42.2 (end‑Q4→Q1→May 11), NAV rose 44.2M → 69.9M → ~90M (Q4→Q1→May 11), Q1 net income was $8.8M (vs Q4 net loss $39.8M), Q1 adjusted EBITDA $19.5M (vs Q4 -$38.9M), cash was ~$16M as of May 11, net cash used in operations was $4.2M in Q1, and management expects continued scaling of revenues and declining core costs to drive the business to positive operating cash flow by year‑end.Hyperion DeFi Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
52
Neutral
Cash Flow
14
Very Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.04M | 813.46K | 57.34K | 3.79K | 0.00 | 14.00M |
| Gross Profit | 664.18K | 510.17K | -3.87M | -12.22K | 0.00 | 12.40M |
| EBITDA | -31.71M | -43.76M | -46.21M | -24.11M | -26.32M | -12.17M |
| Net Income | -32.99M | -45.31M | -49.82M | -27.26M | -28.01M | -12.78M |
Balance Sheet | ||||||
| Total Assets | 70.07M | 51.76M | 3.67M | 28.78M | 31.04M | 31.66M |
| Cash, Cash Equivalents and Short-Term Investments | 7.38M | 6.44M | 2.12M | 14.85M | 22.86M | 19.46M |
| Total Debt | 9.07M | 8.51M | 11.24M | 16.08M | 10.12M | 7.15M |
| Total Liabilities | 11.57M | 10.70M | 16.76M | 19.78M | 13.80M | 11.19M |
| Stockholders Equity | 58.49M | 41.06M | -13.10M | 9.00M | 17.23M | 20.47M |
Cash Flow | ||||||
| Free Cash Flow | -87.95M | -14.77M | -30.28M | -27.81M | -25.98M | -22.49M |
| Operating Cash Flow | -14.52M | -14.77M | -30.12M | -23.84M | -25.11M | -20.87M |
| Investing Cash Flow | -73.43M | -71.95M | -161.48K | -3.97M | -874.75K | -1.62M |
| Financing Cash Flow | 91.40M | 91.05M | 17.55M | 19.79M | 21.51M | 21.46M |
Hyperion DeFi Technical Analysis
Negative
3.85
Price Trends
3.60
Negative
3.53
Negative
4.78
Negative
Market Momentum
-0.07
Negative
44.92
Neutral
33.86
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HYPD, the sentiment is Negative. The current price of 3.85 is above the 20-day moving average (MA) of 3.23, above the 50-day MA of 3.60, and below the 200-day MA of 4.78, indicating a bearish trend. The MACD of -0.07 indicates Negative momentum. The RSI at 44.92 is Neutral, neither overbought nor oversold. The STOCH value of 33.86 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HYPD.
Hyperion DeFi Risk Analysis
Hyperion DeFi disclosed 48 risk factors in its most recent earnings report. Hyperion DeFi reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Hyperion DeFi Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
49 Neutral | $16.73M | -0.85 | -211.73% | ― | 8.92% | 17.50% | |
47 Neutral | $46.38M | -0.21 | -63.54% | ― | 1455.26% | 85.26% | |
47 Neutral | $31.59M | -0.89 | -1344.47% | ― | 13.48% | 43.42% | |
46 Neutral | $50.04M | -6.45 | -15.79% | ― | -42.94% | -529.29% | |
43 Neutral | $22.75M | -1.94 | -165.13% | ― | 7.72% | 34.39% | |
42 Neutral | $43.44M | -1.08 | -81.48% | ― | ― | ― |
* Healthcare Sector Average
HYPD
Hyperion DeFi
3.06
-7.32
-70.52%
CTSO
Cytosorbents
0.36
-0.92
-71.72%
SRTS
Sensus Healthcare
3.04
-1.70
-35.86%
TELA
TELA Bio
0.71
-1.23
-63.66%
ICCM
Icecure Medical
5.96
-23.34
-79.66%
BDMD
Baird Medical Investment Holdings
1.06
-2.60
-71.04%
Hyperion DeFi Corporate Events
Business Operations and StrategyFinancial Disclosures
Hyperion DeFi to Redeploy HYPE After Felix Wind-Down
Positive
Jun 5, 2026
On May 14, 2026, Native Markets, Inc. said it would stop supporting the USDH stablecoin, transfer USDH brand rights to Coinbase, Inc., and promote USDC as an aligned quote asset on Hyperliquid, prompting Hyperion DeFi to reassess its USDH exposure...
Business Operations and StrategyFinancial DisclosuresPrivate Placements and Financing
Hyperion DeFi Raises Capital to Expand Digital Asset Treasury
Positive
May 14, 2026
On May 13, 2026, Hyperion DeFi raised approximately $0.4 million in net proceeds by issuing 132,249 additional common shares to Chardan Capital Markets under a previously granted 30-day over-allotment option tied to its May 5 underwriting agreemen...
Business Operations and StrategyPrivate Placements and Financing
Hyperion DeFi Announces Underwritten Common Stock Offering
Neutral
May 6, 2026
On May 5, 2026, Hyperion DeFi, Inc. entered into an underwriting agreement with Chardan Capital Markets for an underwritten public offering of 2,777,778 common shares at $3.60 per share, with the underwriter purchasing at $3.384 per share. The dea...
Business Operations and StrategyFinancial DisclosuresShareholder Meetings
Hyperion DeFi Reports Strong Growth Amid Crypto Volatility
Positive
Mar 26, 2026
On March 20, 2026, Hyperion DeFi’s board approved third amended and restated bylaws that lower the quorum for shareholder meetings to one-third of voting shares from a simple majority and formally allow shareholder action via written consent...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.